Abstract
ObjectiveTo give a review of the history of SCNP since the first meeting in 1960 with specific focus on UKU.MethodsConsulting the appropriate minutes from the meetings.ResultsOne of the major goals of the SCNP was the standardization of clinical trials with psychotropic drugs. In 1969, the SCNP established a Committee for Clinical Investigations (UKU) with the representation of clinical investigators and the drug industry; moreover, during the 1970s and ’80s, the UKU initiated clinical trialsand contributed to the methodology of clinical investigations with psychotropic drugs. With the decrease in governmental funding and increasing influence of the US Food and Drug Administration on themethodology of clinical investigations around the world in the 1990s, the UKU was dissolved. The changes had a detrimental effect on the developments on the methodology of clinical investigations, and the lack of clinical feedback led to an impasse in psychotropic drug development with some pharmaceutical companies abandoning research in the central nervous system area.ConclusionIt is suggested that a revival of UKU to provide a platform for dialogue among government, industry, and academia could help break the impasse.
Publisher
Cambridge University Press (CUP)
Subject
Biological Psychiatry,Psychiatry and Mental health
Reference16 articles.
1. Current status of psychiatric research in Denmark;Strömgren;Psychiatrie and Psychobiologie,1987
2. The current scope of psychopharmacological research in Europe;Bech;Nord J Psychiatry,1984
3. Scales for Assessment of Diagnosis and Severity of Mental Disorders;Bech;Acta Psychiatrica Scand,1993
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献